CD46975-41 - 0x000000000000736F

Healthy Males & Females

Refresh

* Stipend may pay up to reflected amount.
Start Date: 
October 27, 2026 - 4:00pm
End Date: 
November 25, 2026 - 7:00am

Study Details

Study Number: CD46975
Group Number: 41
Study Requirement: Healthy Normal Male and Female
Stipend: up to $12,750.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat atopic dermititis.
Route of Administration: Oral
Blood Draws: 37

Study Schedule

Schedule Type: Long Term
Study Length: 22 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Wednesday 10/21/2026
Thursday 10/22/2026
Friday 10/23/2026
Monday 10/26/2026
Tuesday 10/27/2026

Doctor Exam Dates:

Event Day Event Date
Wednesday 10/21/2026
Thursday 10/22/2026
Friday 10/23/2026
Monday 10/26/2026
Tuesday 10/27/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 10/27/2026 4:00:00 PM Wednesday 11/18/2026 7:30:00 AM 1 Lincoln
Return Wednesday 11/25/2026 6:00:00 AM Wednesday 11/25/2026 7:00:00 AM 1 Lincoln